At 2.58 t.d. CommSec showed:86 buyers for 6,126,931 units at...

At 2.58 t.d. CommSec showed:

86 buyers for 6,126,931 units at 0.100.....last trade 0.105

The 10 cent psychological factor, moving from point one of a cent to half a cent deviations in trade is interesting.

There has been much discussion this year regarding the progress of Prima and how management, with Martin Rogers, has brought them back from the brink. It is important to recognise the new situation with Prima with regard to finance, IND, the current SP, upcomming Phase IIb trial and the expectation of Orphan Status to boost their strong patents and IP.

Prima are at a fantastic place compared to twelve months ago. My point though, is that many (NOT ALL) of the significant hurdles Prima as a company were facing have been overcome, and we are getting where, although further funds will be needed to complete Phase III trials, it will come down to whether Cvac does what the scientists working on it are professing.

With that in mind I would like to move to the following internet addresses which show the scientific aspect of Cvac moving from its early stages to Phase IIa. I hope this gives everyone an idea of why the 'scientific community are excited about Cvac'.

(i) Regarding Phase I: http://www.lifescientist.com.au/article/149435/prima_publishes_cancer_trial_results_outlines_road_ahead

(ii) Moving to Phase II: http://www.bioshares.com.au/research/bioshares159rbpprr.pdf

(iii) Final Phase IIa results: http://www.biospace.com/news_story.aspx?NewsEntityId=48993

It is getting to the stage where management is able to place the success of Cvac into the scientists hands.

I hope this has been of assistance.

Regards